Polycythemia Vera is a rare blood disease in which the body makes excessive red blood cells. The extra red blood cells make the blood thicker than normal Polycythemia Vera is the most common myeloproliferative neoplasm (MPN), the ultimate phenotype of the JAK2 V1617F mutation. Many individuals with Polycythemia Vera receive treatment with certain drugs (myelosuppressive drugs) that suppress the formation of blood cells by the marrow. For More Information Related to the Polycythemia Vera Market Research Report :- @https://www.delveinsight.com/report-store/polycythemia-vera-market?utm_source=youtube&utm_medium=video&utm_campaign=ypr